Evidence map›Paper›PMID 38674937›Full record

ArticleNutrients2024

Osteogenic Effects of the

Soyeon Hong, Nadzeya Lazerka, Byeong Jun Jeon, Jeong Do Kim, Saruul Erdenebileg, Chu Won Nho, Gyhye Yoo

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Soyeon HongSmart Farm Research Center, Gangneung Institute of Natural Products, Korea Institute of Science and Technology (KIST), Gangneung 25451, Republic of Korea.
Nadzeya LazerkaSmart Farm Research Center, Gangneung Institute of Natural Products, Korea Institute of Science and Technology (KIST), Gangneung 25451, Republic of Korea.ORCID 0009-0000-7974-6072
Byeong Jun JeonSmart Farm Research Center, Gangneung Institute of Natural Products, Korea Institute of Science and Technology (KIST), Gangneung 25451, Republic of Korea.
Jeong Do KimSmart Farm Research Center, Gangneung Institute of Natural Products, Korea Institute of Science and Technology (KIST), Gangneung 25451, Republic of Korea.ORCID 0000-0001-6388-522X
Saruul ErdenebilegSmart Farm Research Center, Gangneung Institute of Natural Products, Korea Institute of Science and Technology (KIST), Gangneung 25451, Republic of Korea.
Chu Won NhoSmart Farm Research Center, Gangneung Institute of Natural Products, Korea Institute of Science and Technology (KIST), Gangneung 25451, Republic of Korea.ORCID 0000-0002-7805-0521
Gyhye YooSmart Farm Research Center, Gangneung Institute of Natural Products, Korea Institute of Science and Technology (KIST), Gangneung 25451, Republic of Korea.ORCID 0000-0002-3033-3178
Korea Institute of Science and Technology · KR

Funding

Korea Institute of Science and Technology 2Z07021
6 · The paper itself

Abstract

Osteoporosis, a disease defined by the primary bone strength due to a low bone mineral density, is a bone disorder associated with increased mortality in the older adult population. Osteoporosis is mainly treated via hormone replacement therapy, bisphosphates, and anti-bone resorption agents. However, these agents exert severe side effects, necessitating the development of novel therapeutic agents. Many studies are focusing on osteogenic agents as they increase the bone density, which is essential for osteoporosis treatment. Here, we aimed to investigate the effects of

Indexed as

Bone DensityDiospyrosOsteoblastsOsteogenesisPlant ExtractsAnimalsBone Morphogenetic Protein 2Bone Morphogenetic Protein 4Cell DifferentiationFemaleMiceOsteoporosisOvariectomyPlant LeavesSignal TransductionTransforming Growth Factor betaBmp2 protein, mouseBone Morphogenetic Protein 2Bone Morphogenetic Protein 4Plant ExtractsTransforming Growth Factor betabone morphogenic protein 2/4 (BMP2/4)Diospyros lotus leaf extract (DLE)osteoblast differentiationosteoporosistransforming growth factor β (TGF β)

Identifiers

PMID38674937
PMCPMC11053699
OpenAlexW4395000290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.